Shield Therapeutics plc (AIM: STX)
Health Care · Pharmaceuticals · GB
£0.05
+11.49% today · -35.3% 1Y
Shield Therapeutics plc (AIM: STX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $70.73M.
Over the last twelve months the share price has lost 35.3%, trading between 0.04 and 0.13.
Tweenvest scores Shield Therapeutics plc across four factors: quality 20/100, value 61/100, growth 100/100. Its strongest factor is growth.
STX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $70.73M
- Revenue (TTM)
- $58.63M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 1.72
- 52-week high
- £0.13
- 52-week low
- £0.04
- Avg volume (3M)
- —
- Shares outstanding
- 1.07B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.